Search results for "Response"

showing 10 items of 4136 documents

In vitro and in silico studies of polycondensed diazine systems as anti-parasitic agents

2012

Abstract Parasitic diseases caused by protozoarian agents are still relevant today more than ever. Recently, we synthesized several polycondensed diazine derivatives by means 1,3-dipolar cycloaddition reactions. A broad selection of these compounds were submitted to in vitro biological screening against Plasmodium falciparum , Leishmania infantum , Trypanosoma brucei , and Trypanosoma cruzi , resulting active at micromolar level. Induced Fit Docking/MM-GBSA studies were performed giving interesting indications about the probable mechanism of action of the most active compounds

Models MolecularTrypanosoma cruziIn silicoPlasmodium falciparumTrypanosoma brucei bruceiClinical BiochemistryPharmaceutical ScienceTrypanosoma bruceiBiochemistryStructure-Activity Relationshipchemistry.chemical_compoundParasitic Sensitivity Testsparasitic diseasesDrug DiscoveryLeishmania infantumTrypanosoma cruziMolecular BiologyDiazineAntiparasitic AgentsDose-Response Relationship DrugMolecular StructurebiologyOrganic ChemistryPlasmodium falciparumAnti-parasitic Plasmodium Leishmania Trypanosoma Diazine Induced fit docking/MM-GBSAbiology.organism_classificationSettore CHIM/08 - Chimica FarmaceuticaHydrazineschemistryBiochemistryDocking (molecular)TrypanosomaMolecular MedicineLeishmania infantumBioorganic & Medicinal Chemistry Letters
researchProduct

Palladium(II)-Stabilized Pyridine-2-Diazotates: Synthesis, Structural Characterization, and Cytotoxicity Studies

2018

Well-defined diazotates are scarce. Here we report the synthesis of unprecedented homoleptic palladium(II) diazotate complexes. The palladium(II)-mediated nitrosylation of 2-aminopyridines with NaNO2 results in the formation of metal-stabilized diazotates, which were found to be cytotoxic to human ovarian cancer cells.

Models Molecularinorganic chemicalsCell SurvivalPyridinesPyrazine Diazohydroxidechemistry.chemical_elementAntineoplastic AgentsorganometalliyhdisteetCrystallography X-Ray010402 general chemistry01 natural sciencesInorganic ChemistryStructure-Activity Relationshipchemistry.chemical_compoundCoordination ComplexesCell Line Tumororganometallic compoundsPyridineHumansCytotoxic T cellsytotoksisuusPhysical and Theoretical ChemistryHomolepticCytotoxicityta116Cell ProliferationDose-Response Relationship DrugMolecular Structure010405 organic chemistryNitrosylationCombinatorial chemistry0104 chemical sciencesHEK293 Cellssyöpäsolutchemistrycancer cellsOvarian cancer cellscytotoxicityDrug Screening Assays AntitumorAzo CompoundsPalladiumPalladiumInorganic Chemistry
researchProduct

A Primary Evaluation of Potential Small-Molecule Inhibitors of the Astacin Metalloproteinase Ovastacin, a Novel Drug Target in Female Infertility Tre…

2020

Abstract Despite huge progress in hormonal therapy and improved in vitro fertilization methods, the success rates in infertility treatment are still limited. A recently discovered mechanism revealed the interplay between the plasma protein fetuin‐B and the cortical granule‐based proteinase ovastacin to be a novel key mechanism in the regulation of fertilization. Upon sperm–egg fusion, cleavage of a distinct zona pellucida component by ovastacin destroys the sperm receptor, enhances zona robustness, and eventually provides a definitive block against polyspermy. An untimely onset of this zona hardening prior to fertilization would consequently result in infertility. Physiologically, this proc…

Models Molecularmedicine.medical_treatmentHydroxamic Acids01 natural sciencesBiochemistryMiceHuman fertilizationIn vitro fertilizationDrug DiscoveryGeneral Pharmacology Toxicology and PharmaceuticsAminesZona pellucidametzincinseducation.field_of_studyMolecular StructureCommunicationFemale infertilitySperm receptorPolyspermyCell biologymedicine.anatomical_structureastacinsHydroxamateMolecular MedicineFemalemetalloproteinaseinfertilityInfertility FemaleInfertilityendocrine systemCortical granuleBiologySmall Molecule LibrariesStructure-Activity RelationshipmedicineAnimalseducationPharmacologyIn vitro fertilisationDose-Response Relationship Drugurogenital system010405 organic chemistryOrganic Chemistryin vitro fertilizationmedicine.diseaseovastacinCommunications0104 chemical sciences010404 medicinal & biomolecular chemistryBiocatalysisMetalloproteasesChemMedChem
researchProduct

Stress distribution of complete-arch implant-supported prostheses reinforced with silica-nylon mesh

2019

Made available in DSpace on 2020-12-12T01:20:51Z (GMT). No. of bitstreams: 0 Previous issue date: 2019-01-01 Background: This study evaluated the presence of a silica-nylon mesh and two cantilever lengths on the biomechanical behavior of complete-arch implant-supported prostheses. Material and Methods: Twenty-four (24) complete mandibular arch implant-supported prostheses were divided into 4 groups according to the presence of reinforcing mesh (with or without) and the cantilever length (molar-15 mm or premolar-5 mm). The specimens were submitted to strain gauge analysis (30-kgf, 10 s) at different points (molar and premolar). Three-dimensional models were created based on the in vitro spec…

MolarCantileverMaterials sciencemedicine.medical_treatmentProsthesisStress (mechanics)03 medical and health sciences0302 clinical medicinestomatognathic systemmedicinePremolarGeneral DentistryStrain gaugeStress concentrationOrthodonticsResearchDental implantsFinite element analysis030206 dentistry:CIENCIAS MÉDICAS [UNESCO]Finite element methodProsthetic dentistrymedicine.anatomical_structureUNESCO::CIENCIAS MÉDICASBiomechanical response030217 neurology & neurosurgeryJournal of Clinical and Experimental Dentistry
researchProduct

The cold shock response of the psychrotrophic bacterium Pseudomonas fragi involves four low-molecular-mass nucleic acid-binding proteins

1997

The psychrotrophic bacterium Pseudomonas fragi was subjected to cold shocks from 30 or 20 to 5 degrees C. The downshifts were followed by a lag phase before growth resumed at a characteristic 5 degrees C growth rate. The analysis of protein patterns by two-dimentional gel electrophoresis revealed overexpression of 25 or 17 proteins and underexpression of 12 proteins following the 30- or 20-to-5 degrees C shift, respectively. The two downshifts shared similar variations of synthesis of 20 proteins. The kinetic analysis distinguished the induced proteins into cold shock proteins (Csps), which were rapidly but transiently overexpressed, and cold acclimation proteins (Caps), which were more or …

Molecular Sequence DataAdaptation BiologicalBiologyMicrobiologyPolymerase Chain Reaction03 medical and health sciencesHeat acclimationBacterial ProteinsPseudomonas fragiHeat shock proteinNucleic AcidsPseudomonasCold acclimationElectrophoresis Gel Two-DimensionalAmino Acid SequenceCloning MolecularMolecular BiologyPeptide sequence[SDV.MP] Life Sciences [q-bio]/Microbiology and ParasitologyHeat-Shock ProteinsComputingMilieux_MISCELLANEOUS030304 developmental biologyGel electrophoresis0303 health sciencesBase SequenceSequence Homology Amino Acid030306 microbiologySequence Analysis DNACold-shock domainbiology.organism_classificationMolecular biologyCold shock responseCold TemperatureDNA-Binding Proteins[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyBiochemistryGenes BacterialCarrier ProteinsSequence AnalysisGenome BacterialResearch ArticleProtein Binding
researchProduct

Conserved Structure and Promoter Sequence Similarity in the Mouse and Human Genes Encoding the Zinc Finger Factor BERF-1/BFCOL1/ZBP-89

2001

Abstract We have characterized the genomic structure of the mouse Zfp148 gene encoding Beta-Enolase Repressor Factor-1 (BERF-1), a Kruppel-like zinc finger protein involved in the transcriptional regulation of several genes, which is also termed ZBP-89, BFCOL1. The cloned Zfp148 gene spans 110 kb of genomic DNA encompassing the 5′-end region, 9 exons, 8 introns, and the 3′-untranslated region. The promoter region displays the typical features of a housekeeping gene: a high G+C content and the absence of canonical TATA and CAAT boxes consistent with the multiple transcription initiation sites determined by primary extension analysis. Computer-assisted search in the human genome database allo…

Molecular Sequence DataResponse elementBiophysicsCodon InitiatorRegulatory Sequences Nucleic AcidBiologyBiochemistryConserved non-coding sequenceMiceExonAnimalsHumansPromoter Regions GeneticMolecular BiologyGeneConserved SequenceGeneticsZinc fingerBase SequenceAlternative splicingIntronZinc FingersPromoterExonsCell BiologyIntronsDNA-Binding ProteinsAlternative Splicing5' Untranslated RegionsTranscription FactorsBiochemical and Biophysical Research Communications
researchProduct

Rational design of allosteric modulators of the aromatase enzyme: An unprecedented therapeutic strategy to fight breast cancer.

2019

Estrogens play a key role in cellular proliferation of estrogen-receptor-positive (ER+) breast cancers (BCs). Suppression of estrogen production by competitive inhibitors of the enzyme aromatase (AIs) is currently one of the most effective therapies against ER + BC. Yet, the development of acquired resistance, after prolonged treatments with AIs, represents a clinical major concern. Serendipitous findings indicate that aromatase may be non-competitively inhibited by clinically employed drugs and/or industrial chemicals. Here, by performing in silico screening on two putative allosteric sites, molecular dynamics and free energy simulations, supported by enzymatic and cell-based assays, we id…

Molecular dynamicmedicine.drug_classIn silicoAllosteric regulationCytochromes P450; Aromatase; Molecular dynamics; Aromatase inhibitors; Docking; Breast cancer; Resistance onset; Mixed inhibition mechanismAntineoplastic AgentsBreast NeoplasmsMolecular dynamicsMolecular Dynamics SimulationDockingStructure-Activity RelationshipBreast cancerBreast cancerAromataseAllosteric RegulationCell Line TumorDrug DiscoverymedicineResistance onsetHumansMixed inhibition mechanismAromataseEnzyme InhibitorsCell ProliferationPharmacologychemistry.chemical_classificationbiologyDose-Response Relationship DrugMolecular StructureChemistryOrganic ChemistryRational designAromatase inhibitorGeneral Medicinemedicine.diseaseEnzymeAromatase inhibitorsSettore CHIM/03 - Chimica Generale E InorganicaEstrogenDocking (molecular)Drug Designbiology.proteinCancer researchDrug Screening Assays AntitumorCytochromes P450European journal of medicinal chemistry
researchProduct

Design, synthesis and biological evaluation of novel stilbene-based antitumor agents

2008

A series of novel stilbene derivatives has been synthesized and studied with the main goal to investigate SAR of the amino compound 1a, as well as to improve its water solubility, a potentially negative aspect of the molecule that could be a serious obstacle for a pre-clinical development. We have obtained derivatives with good cytotoxic activity, in particular, the derivatives 5c and 6b could represent two novel leads for further investigation. Compound 8b, a morpholino-carbamate derivative, prodrug of 1a, has a very good solubility in water, and is active in suppressing growth of tumor cells at a concentration of 5000 nM, which is a concentration 100 times higher than the parent stilbene …

Molecular modelClinical BiochemistryAntitumor agents; Prodrugs; Stilbenes;Pharmaceutical ScienceAntineoplastic AgentsBiochemistryChemical synthesisStructure-Activity RelationshipTubulinCell Line TumorStilbenesDrug DiscoveryHumansMoleculeOrganic chemistryProdrugsAminesSolubilityMolecular BiologyCell Proliferationchemistry.chemical_classificationAqueous solutionDose-Response Relationship DrugOrganic ChemistryAromatic amineProdrugCombinatorial chemistryIn vitroSolubilitychemistryDrug DesignMolecular MedicineBioorganic & Medicinal Chemistry
researchProduct

Impact of exogenous lactate on survival and radioresponse of carcinoma cells in vitro

2009

Tumour lactate levels have been shown to correlate with high radioresistance in tumour models in vivo. The study aimed to evaluate the impact of pathophysiological extracellular lactate concentrations and acidosis on the in vitro survival and radioresponse of various cancer cell lines.HCT-116, HT29 (colorectal) and FaDu (HNSCC) carcinoma cells were studied. Lactate release rates were determined, and expression of the monocarboxylate transporter MCT1 and its cofactor CD147 were monitored by immunofluorescence and flow cytometry. Colony formation was compared for cells exposed to 20 mM exogenous lactate, acidosis (pH 6.4) and lactate plus acidosis relative to control and dose response curves …

Monocarboxylic Acid TransportersCell SurvivalIn Vitro TechniquesRadiation ToleranceFlow cytometryAndrologyCell Line TumorRadioresistanceExtracellularmedicineHumansRadiology Nuclear Medicine and imagingLactic AcidClonogenic assayTumor Stem Cell AssayAcidosisMonocarboxylate transporterSymportersRadiological and Ultrasound Technologybiologymedicine.diagnostic_testCarcinomaHydrogen-Ion ConcentrationHCT116 CellsDose–response relationshipGlucoseBiochemistryCancer cellBasiginbiology.proteinmedicine.symptomAcidosisHT29 CellsInternational Journal of Radiation Biology
researchProduct

Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patien…

2015

OBJECTIVE: To compare lipid-lowering efficacy of adding alirocumab to rosuvastatin versus other treatment strategies (NCT01730053).METHODS: Patients receiving baseline rosuvastatin regimens (10 or 20 mg) were randomized to: add-on alirocumab 75 mg every-2-weeks (Q2W) (1-mL subcutaneous injection via pre-filled pen); add-on ezetimibe 10 mg/day; or double-dose rosuvastatin. Patients had cardiovascular disease (CVD) and low-density lipoprotein cholesterol (LDL-C) ≥70 mg/dL (1.8 mmol/L) or CVD risk factors and LDL-C ≥100 mg/dL (2.6 mmol/L). In the alirocumab group, dose was blindly increased at Week 12 to 150 mg Q2W (also 1-mL volume) in patients not achieving their LDL-C target. Primary endpoi…

Monoclonal antibodymedicine.medical_specialtyTime FactorsSettore MED/09 - Medicina InternaInjections SubcutaneousHypercholesterolemiaUrology030204 cardiovascular system & hematologyPharmacologyAntibodies Monoclonal Humanizedlaw.inventionPCSK9Rosuvastatin03 medical and health sciences0302 clinical medicineDouble-Blind MethodEzetimibeRandomized controlled triallawmedicineClinical endpointHumansLow-density lipoprotein cholesterolRosuvastatinIn patient030212 general & internal medicineRosuvastatin CalciumAlirocumab; Ezetimibe; Low-density lipoprotein cholesterol; Monoclonal antibody; PCSK9; Rosuvastatin; Cardiology and Cardiovascular MedicineRetrospective StudiesAlirocumabDose-Response Relationship Drugbusiness.industryAnticholesteremic AgentsPCSK9Antibodies Monoclonalnutritional and metabolic diseasesCholesterol LDLEzetimibeRosuvastatin CalciumTreatment OutcomeCardiovascular DiseasesDrug Therapy CombinationHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessCardiology and Cardiovascular MedicineFollow-Up StudiesAlirocumabmedicine.drugAtherosclerosis
researchProduct